Novartis already received FDA approval of ITVISMA as a gene therapy for the treatment of patients with SMA. Read why NVS ...

Since then, the Social Security Administration has issued approximately 548.3 million unique Social Security numbers and an ...

The Securing Agriculture’s Workforce Act would reshape the H-2A visa program by opening it to more types of agricultural work and giving ...

The program’s broad availability for Oregonians is codified into state law and not up to state regulators Oregon’s landmark effort allowing adults older than 21 to access psilocybin has evolved ...

While the NAB had pushed to limit the auction to 100 MHz, commission will vote July 22 to auction a larger amount next year When you purchase through links on our site, we may earn an affiliate ...

It was reported recently by researchers that declining mental ability in middle age may predict a person's risk of death. Previous studies have shown that declining mental ability among the elderly ...

iverse corporate team in a conference room smiling and clapping for an AI robot. A new Board Intelligence survey reveals that 98% of mid-market company boards are actively discussing or implementing ...

The city of Columbia is phasing out the CoMo Park Card Program later this year, according to a news release from the city of Columbia. CoMo Park Cards were prepaid parking cards that could be reloaded ...

LANSING, Mich. (WLNS) — A new free training program is aiming to help small business owners across Mid-Michigan strengthen their operations and stay competitive in a changing marketplace. The Lansing ...

June's first week has begun on a high note for cinephiles, with multiple releases lined up. From Bandar, Hai Jawani Toh Ishq Hona Hai, and Peddi to He-Man And The Masters Of The Universe, several ...

Getting your Trinity Audio player ready... EDWARDSVILLE — Relief with a splash of awesomeness blended in. That’s the thought that ran through Avery Tinney’s mind as she stepped on home plate for the ...

Biogen and Denali’s Parkinson’s disease drug failed to significantly slow disease progression in a Phase 2b study, missing both primary and secondary endpoints. Biogen and Denali Therapeutics’ ...